QUALITY OF LIFE AND FATIGUE IN DE NOVO LIVER TRANSPLANT RECIPIENTS; 24-MONTH RESULTS FROM A MULTI-CENTER OPEN LABEL, RANDOMIZED CONTROLLED STUDY

被引：0
|
作者：
Mulder, Midas [1 ,2 ]
Murad, Sarwa Darwish [2 ,3 ]
Busschbach, Jan [4 ]
Verhey, Elke [3 ]
de Jong, Koert [5 ]
van den Berg, Aad A. P. [6 ]
van Hoek, Bart [7 ]
Alwayn, Ian [8 ]
Erler, Nicole [9 ]
Polak, Wojciech [2 ,10 ]
de Winter, Brenda [1 ]
den Hoed, Caroline [2 ,3 ]
Metselaar, Herold [2 ,3 ]
机构：
[1] Univ Med Ctr Rotterdam, Dept Hosp Pharm, Erasmus MC, Rotterdam, Netherlands
[2] Univ Med Ctr Rotterdam, Erasmus MC Transplantat Inst, Erasmus MC, Rotterdam, Netherlands
[3] Univ Med Ctr Rotterdam, Dept Gastroenterol & Hepatol, Erasmus MC, Rotterdam, Netherlands
[4] Univ Med Ctr Rotterdam, Sect Med Psychol & Psychotherapy, Dept Psychiat, Erasmus MC, Rotterdam, Netherlands
[5] Univ Med Ctr Groningen, Dept Surg, UMCG, Groningen, Netherlands
[6] Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, UMCG, Groningen, Netherlands
[7] Leiden Univ, Med Ctr, LUMC, Dept Gastroenterol & Hepatol, Leiden, Netherlands
[8] Leiden Univ, Med Ctr, LUMC, Dept Surg, Leiden, Netherlands
[9] Univ Med Ctr Rotterdam, Dept Biostat, Erasmus MC, Rotterdam, Netherlands
[10] Univ Med Ctr Rotterdam, Dept Surg, Erasmus MC, Rotterdam, Netherlands
来源：
TRANSPLANT INTERNATIONAL | 2021年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
OP336
引用
收藏
页码：169 / 170
页数：2
相关论文
共 50 条
  • [21] RANDOMIZED, MULTICENTER STUDY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: RESULTS AT 24 MONTHS
    Duvoux, C.
    Saliba, F.
    Durand, F.
    Neau-Cransac, N.
    Hardwigsen, J.
    Pageaux, G.
    Boleslawski, E.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 2 - 2
  • [22] EFFICACY AND SAFETY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: 12 MONTH RESULTS OF A PHASE III, RANDOMIZED, CONTROLLED STUDY
    Saliba, Faouzi
    De Simone, Paolo
    Nevens, Frederik
    De Carlis, Luciano
    Metselaar, Herold
    Beckebaum, Susanne
    Jonas, Sven
    Sudan, Debra
    Fischer, Lutz
    Fung, John J.
    Jiang, Hai
    Junge, Guido
    HEPATOLOGY, 2011, 54 : 1430A - 1431A
  • [23] Effect of Induction Therapy on Outcomes of De Novo Renal Transplant Recipients Receiving Everolimus with Reduced-Dose Calcineurin Inhibitor: 24-Month Results from the TRANSFORM Study.
    Oberbauer, R.
    Vincenti, F.
    Viklicky, O.
    Huynh-Do, U.
    Kim, D.
    Cruzado, J. M.
    Qazi, Y.
    Kim, M. S.
    Narvekar, P.
    Gutierrez, M. P. Hernandez
    Bernhardt, P.
    Kuypers, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 558 - 558
  • [24] Assessment of Proteinuria Reported as Adverse Events in De Novo Renal Transplant Recipients Receiving an Everolimus-Based Regimen: 24-Month Results from TRANSFORM.
    Legendre, C.
    Berger, S.
    Oppenheimer, F.
    Wiseman, A.
    Steinberg, S.
    Viklicky, O.
    Russ, G.
    Danguilan, R.
    Basic-Jukic, N.
    Mor, E.
    Narvekar, P.
    Gutierrez, M. P. Hernandez
    Bernhardt, P.
    Sommerer, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 693 - 694
  • [25] 24 month safety results of a randomized, multicenter, double-blind study of everolimus vs azathioprine in de novo heart transplant recipients.
    Eisen, H
    Kobashigawa, J
    Starling, RC
    Cretin, N
    Jaffe, J
    Murphy, J
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 282 - 283
  • [26] 24-MONTH RESULTS FROM THE H2307 PIVOTAL STUDY: MTOR INHIBITION WITH EVEROLIMUS IN DE NOVO LIVING DONOR LIVER TRANSPLANTATION
    Braun, F.
    Meier, M.
    Sips, C.
    Kroeger, I.
    Settmacher, U.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 17 - 17
  • [27] High-intensity interval training and health-related quality of life in de novo heart transplant recipients – results from a randomized controlled trial
    Katrine Rolid
    Arne K. Andreassen
    Marianne Yardley
    Einar Gude
    Elisabeth Bjørkelund
    Anne R. Authen
    Ingelin Grov
    Kjell I. Pettersen
    Christian H. Dall
    Kristjan Karason
    Kaspar Broch
    Lars Gullestad
    Kari Nytrøen
    Health and Quality of Life Outcomes, 18
  • [28] High-intensity interval training and health-related quality of life in de novo heart transplant recipients - results from a randomized controlled trial
    Rolid, Katrine
    Andreassen, Arne K.
    Yardley, Marianne
    Gude, Einar
    Bjorkelund, Elisabeth
    Authen, Anne R.
    Grov, Ingelin
    Pettersen, Kjell I.
    Dall, Christian H.
    Karason, Kristjan
    Broch, Kaspar
    Gullestad, Lars
    Nytroen, Kari
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2020, 18 (01)
  • [29] Results of a 6-month, multicenter, open-label, prospective study concerning efficacy and safety of mycophenolate sodium in de novo kidney transplant recipients
    Wyzgal, J.
    Niemczyk, M.
    Ziolkowski, J.
    Durlik, M.
    Wiecek, A.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (09) : 2730 - 2732
  • [30] EFFECT OF DONOR AGE ON EFFICACY AND SAFETY OF DE NOVO RENAL TRANSPLANT RECIPIENTS RECEIVING EVEROLIMUS WITH REDUCED-EXPOSURE CALCINEURIN INHIBITOR REGIMEN: 24-MONTH RESULTS FROM THE TRANSFORM STUDY
    Pascual, Julio
    Legendre, Christophe
    Vincenti, Flavio
    Tedesco, Helio
    Witzke, Oliver
    Viklicky, Ondrej
    Cruzado, Josep M.
    Hernandez, Maria-Pilar
    Narvekar, Prachiti
    Bernhardt, Peter
    Kuypers, Dirk
    TRANSPLANT INTERNATIONAL, 2019, 32 : 79 - 79
12345